LBPH

Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LBPH

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/25	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/05/25	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/05/07	05 : 01	Business Wire	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/05/03	05 : 01	Business Wire	Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/04/03	22 : 00	Business Wire	Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/04/03	05 : 00	Business Wire	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/03/13	05 : 01	Business Wire	Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/03/02	06 : 01	Business Wire	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/02/03	06 : 30	Business Wire	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/02/01	22 : 30	Business Wire	Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/09	06 : 05	Business Wire	Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/05	06 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/05	06 : 48	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/04	11 : 40	Business Wire	Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/04	10 : 59	Edgar (US Regulatory)	Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/03	06 : 54	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/03	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/03	06 : 01	Business Wire	Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/02	23 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/02	22 : 00	Business Wire	Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2024/01/02	06 : 47	Business Wire	Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/29	22 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/29	22 : 30	Business Wire	Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/22	06 : 00	Business Wire	Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/04	05 : 01	Business Wire	Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/03	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/03	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/03	05 : 01	Business Wire	Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/11/01	21 : 30	Business Wire	Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November	NASDAQ:LBPH	Longboard Pharmaceuticals Inc
2023/10/11	22 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LBPH	Longboard Pharmaceuticals Inc